Home・Aandelen Lijst・Agilent Technologies Inc

Agilent Technologies Inc

Gesloten

SectorGezondheidszorg

139.31 -0.27

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

138.06

Max

140.31

Belangrijke statistieken
By Trading Economics
Inkomsten	34M 339M
Verkoop	37M 1.8B
K/W Sectorgemiddelde	27.745 64.641
EPS	1.49
Dividendrendement	0.73
Winstmarge	18.474
Werknemers	18,000
EBITDA	44M 500M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+12.11% upside

Dividenden
By Acuity
Dividendrendement Sectorgemiddelde	0.73% 2.31%
Volgende Winsten	26 aug 2026
Volgende dividenddatum	21 okt 2026
Volgende Ex Dividend datum	29 sep 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	6.5B 39B
Vorige openingsprijs	139.58
Vorige sluitingsprijs	139.31

Nieuwssentiment

By Acuity

16%

84%

22 / 340 Rangschikking in Healthcare

Agilent Technologies Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 jul 2026, 20:03 UTC

Agilent Technologies Inc shares are lower today, impacted by a decline in the Life Sciences Tools & Services sub-sector. No specific news was identified.

30 jul 2026, 19:58 UTC

Agilent Technologies Inc. is trading lower, continuing a decline since Wednesday's close. The Nasdaq 100 Index has increased, contrasting with Agilent's performance.

29 jul 2026, 19:56 UTC

Agilent Technologies Inc shares are lower amid broader market pressures from rising crude oil prices and inflation concerns affecting equities.

28 jul 2026, 23:41 UTC

Agilent Technologies shares declined in after-market trading, reflecting broader pressures in technology due to concerns over AI spending and competition from Chinese chipmakers.

27 jul 2026, 22:36 UTC

Agilent Technologies Inc shares are higher in after-market trading, supported by strong performance. The stock remains above its 20-day moving average.

24 jul 2026, 19:07 UTC

News

Agilent Technologies Inc shares are trading lower amid concerns over sales trends and underperformance compared to healthcare peers. The stock remains above its 20-day moving average.

23 jul 2026, 20:03 UTC

Correlated Moves

News

Agilent Technologies received EU certification for its PD-L1 IHC 22C3 diagnostic, boosting shares during Thursday's session. This marks the eighth CE-marked indication in the EU.

22 jul 2026, 21:46 UTC

Correlated Moves

Agilent Technologies Inc. is higher in after-market trading, supported by a rise in Thermo Fisher Scientific Inc. and overall life sciences sector performance.

21 jul 2026, 20:02 UTC

News

Agilent Technologies has received FDA approval for its PD-L1 IHC 28-8 assay, boosting shares as analysts express positive sentiment on its future prospects.

20 jul 2026, 19:22 UTC

News

Agilent Technologies Inc. shares are lower amid broader market declines and rising Treasury yields, despite a "Moderate Buy" consensus from analysts.

Peer Vergelijking

Prijswijziging

Agilent Technologies Inc Prognose

Koersdoel

By TipRanks

12.11% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 155.13 USD 12.11%

Hoogste 180 USD

Laagste 135 USD

Gebaseerd op 16 Wall Street-analisten die 12-maands prijsdoelen bieden voor Agilent Technologies Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

16 ratings

Buy

Hold

Sell

Gebaseerd op 16 analisten die aandelenratings hebben gegeven aan Agilent Technologies Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

22 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.